annual total liabilities:
$191.95M+$18.57M(+10.71%)Summary
- As of today (September 17, 2025), AVDL annual total liabilities is $191.95 million, with the most recent change of +$18.57 million (+10.71%) on December 31, 2024.
- During the last 3 years, AVDL annual total liabilities has risen by +$22.93 million (+13.57%).
- AVDL annual total liabilities is now -14.79% below its all-time high of $225.27 million, reached on December 31, 2022.
Performance
AVDL Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$96.45M+$2.57M(+2.74%)Summary
- As of today (September 17, 2025), AVDL quarterly total liabilities is $96.45 million, with the most recent change of +$2.57 million (+2.74%) on June 1, 2025.
- Over the past year, AVDL quarterly total liabilities has increased by +$9.21 million (+10.56%).
- AVDL quarterly total liabilities is now -63.58% below its all-time high of $264.81 million, reached on March 31, 2018.
Performance
AVDL quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
AVDL Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.7% | +10.6% |
| 3 y3 years | +13.6% | -40.2% |
| 5 y5 years | +6.3% | -39.5% |
AVDL Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.8% | +13.6% | -57.2% | +66.9% |
| 5 y | 5-year | -14.8% | +28.5% | -57.2% | +66.9% |
| alltime | all time | -14.8% | +3179.6% | -63.6% | +1547.8% |
AVDL Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $96.45M(+2.7%) |
| Mar 2025 | - | $93.88M(-51.1%) |
| Dec 2024 | $191.95M(+10.7%) | $191.95M(+129.6%) |
| Sep 2024 | - | $83.59M(-4.2%) |
| Jun 2024 | - | $87.23M(-2.5%) |
| Mar 2024 | - | $89.52M(-48.4%) |
| Dec 2023 | $173.39M(-23.0%) | $173.39M(+86.5%) |
| Sep 2023 | - | $92.95M(+60.9%) |
| Jun 2023 | - | $57.78M(-67.7%) |
| Mar 2023 | - | $178.91M(-20.6%) |
| Dec 2022 | $225.27M(+33.3%) | $225.27M(+42.4%) |
| Sep 2022 | - | $158.20M(-1.9%) |
| Jun 2022 | - | $161.27M(-2.8%) |
| Mar 2022 | - | $165.90M(-1.8%) |
| Dec 2021 | $169.02M(+13.2%) | $169.02M(+2.4%) |
| Sep 2021 | - | $165.13M(+0.9%) |
| Jun 2021 | - | $163.71M(+4.6%) |
| Mar 2021 | - | $156.44M(+4.7%) |
| Dec 2020 | $149.37M(-17.3%) | $149.37M(-4.5%) |
| Sep 2020 | - | $156.44M(-1.8%) |
| Jun 2020 | - | $159.28M(-9.3%) |
| Mar 2020 | - | $175.66M(-2.8%) |
| Dec 2019 | $180.63M(-3.7%) | $180.63M(-1.2%) |
| Sep 2019 | - | $182.85M(-0.3%) |
| Jun 2019 | - | $183.49M(+0.2%) |
| Mar 2019 | - | $183.20M(-2.3%) |
| Dec 2018 | $187.52M(+11.8%) | $187.52M(-7.7%) |
| Sep 2018 | - | $203.26M(-6.2%) |
| Jun 2018 | - | $216.69M(-18.2%) |
| Mar 2018 | - | $264.81M(+57.9%) |
| Dec 2017 | $167.70M(-17.6%) | $167.70M(-7.3%) |
| Sep 2017 | - | $180.96M(-0.8%) |
| Jun 2017 | - | $182.43M(-8.6%) |
| Mar 2017 | - | $199.61M(-1.9%) |
| Dec 2016 | $203.41M(+39.4%) | $203.41M(-3.7%) |
| Sep 2016 | - | $211.15M(+6.7%) |
| Jun 2016 | - | $197.87M(+6.8%) |
| Mar 2016 | - | $185.31M(+22.4%) |
| Dec 2015 | $145.95M(-2.3%) | $151.41M(-7.8%) |
| Mar 2015 | - | $164.16M(+9.9%) |
| Dec 2014 | $149.31M(+7.0%) | $149.31M(+20.1%) |
| Sep 2014 | - | $124.34M(+6.5%) |
| Jun 2014 | - | $116.77M(+12.7%) |
| Mar 2014 | - | $103.61M(-25.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $139.49M(+60.7%) | $139.49M(+5.7%) |
| Sep 2013 | - | $131.92M(+2.7%) |
| Jun 2013 | - | $128.47M(+27.1%) |
| Mar 2013 | - | $101.05M(+16.4%) |
| Dec 2012 | $86.81M(+119.2%) | $86.81M(-19.9%) |
| Jun 2012 | - | $108.35M(+2.8%) |
| Mar 2012 | - | $105.43M(+166.2%) |
| Dec 2011 | $39.61M(+8.3%) | $39.61M(-1.8%) |
| Sep 2011 | - | $40.33M(-8.8%) |
| Jun 2011 | - | $44.22M(+23.0%) |
| Mar 2011 | - | $35.96M(-1.6%) |
| Dec 2010 | $36.56M(-23.3%) | $36.56M(-16.8%) |
| Sep 2010 | - | $43.92M(-7.9%) |
| Dec 2009 | $47.67M(+14.9%) | $47.67M(+14.9%) |
| Dec 2008 | $41.50M(-8.6%) | $41.50M(-8.6%) |
| Dec 2007 | $45.40M(+8.4%) | $45.40M(-6.3%) |
| Sep 2007 | - | $48.48M(+2.2%) |
| Jun 2007 | - | $47.45M(+17.3%) |
| Mar 2007 | - | $40.44M(-3.4%) |
| Dec 2006 | $41.87M(+11.1%) | $41.87M(+22.2%) |
| Jun 2006 | - | $34.27M(+1.5%) |
| Mar 2006 | - | $33.78M(-10.4%) |
| Dec 2005 | $37.70M(+30.7%) | $37.70M(+12.7%) |
| Sep 2005 | - | $33.45M(-10.8%) |
| Jun 2005 | - | $37.48M(+29.2%) |
| Mar 2005 | - | $29.00M(+0.5%) |
| Dec 2004 | $28.85M(-18.0%) | $28.85M(+5.0%) |
| Sep 2004 | - | $27.49M(-12.6%) |
| Jun 2004 | - | $31.46M(-6.3%) |
| Mar 2004 | - | $33.58M(-4.6%) |
| Dec 2003 | $35.19M(+226.1%) | $35.19M(+180.6%) |
| Sep 2003 | - | $12.54M(-5.1%) |
| Jun 2003 | - | $13.21M(+5.6%) |
| Mar 2003 | - | $12.51M(+15.9%) |
| Dec 2002 | $10.79M(+1.5%) | $10.79M(+11.1%) |
| Sep 2002 | - | $9.72M(-8.6%) |
| Dec 2001 | $10.63M(+12.2%) | $10.63M(+12.2%) |
| Dec 2000 | $9.48M(+61.9%) | $9.48M(+61.9%) |
| Dec 1999 | $5.85M(-22.3%) | $5.85M(-22.3%) |
| Dec 1998 | $7.53M(+4.0%) | $7.53M(+0.4%) |
| Mar 1998 | - | $7.50M(+4.2%) |
| Dec 1997 | $7.25M(+6.6%) | $7.20M(+5.9%) |
| Dec 1996 | $6.80M | $6.80M(+9.7%) |
| Mar 1996 | - | $6.20M |
FAQ
- What is Avadel Pharmaceuticals plc annual total liabilities?
- What is the all time high annual total liabilities for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc annual total liabilities year-on-year change?
- What is Avadel Pharmaceuticals plc quarterly total liabilities?
- What is the all time high quarterly total liabilities for Avadel Pharmaceuticals plc?
- What is Avadel Pharmaceuticals plc quarterly total liabilities year-on-year change?
What is Avadel Pharmaceuticals plc annual total liabilities?
The current annual total liabilities of AVDL is $191.95M
What is the all time high annual total liabilities for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high annual total liabilities is $225.27M
What is Avadel Pharmaceuticals plc annual total liabilities year-on-year change?
Over the past year, AVDL annual total liabilities has changed by +$18.57M (+10.71%)
What is Avadel Pharmaceuticals plc quarterly total liabilities?
The current quarterly total liabilities of AVDL is $96.45M
What is the all time high quarterly total liabilities for Avadel Pharmaceuticals plc?
Avadel Pharmaceuticals plc all-time high quarterly total liabilities is $264.81M
What is Avadel Pharmaceuticals plc quarterly total liabilities year-on-year change?
Over the past year, AVDL quarterly total liabilities has changed by +$9.21M (+10.56%)